236 results
8-K
EX-10.1
IGC
IGC Pharma Inc
27 Mar 24
IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
6:42pm
sought independent legal, investment and tax advice to the extent that it has deemed necessary or appropriate in connection with its decision
8-K
EX-10.1
IGC
IGC Pharma Inc
21 Mar 24
Entry into a Material Definitive Agreement
7:34pm
or supplemented by a subsequent submission).
(t) Tax Law Compliance. Each of the Company and its subsidiaries has (a) filed all foreign, federal, state … and local tax returns (as hereinafter defined) required to be filed with taxing authorities prior to the date hereof or has duly obtained extensions
424B5
IGC
IGC Pharma Inc
21 Mar 24
Prospectus supplement for primary offering
7:30pm
income tax considerations relating to the securities, and the securities exchange or market, if any, on which the securities will be listed.
We may … ;
a discussion of any material U.S. federal income tax considerations of holding or exercising the warrants;
the terms of the securities issuable upon
424B5
y80ery0j6
31 Jan 24
Prospectus supplement for primary offering
4:04pm
8-K
EX-10.1
grousda4nxetl2
27 Oct 23
Entry into a Material Definitive Agreement
5:21pm
424B5
0ilql6acrjt5bni
27 Oct 23
Prospectus supplement for primary offering
4:38pm
S-8
EX-10.2
zxe5h7rxp
3 Oct 23
Registration of securities for employees
7:27pm
8-K
yo1oht
7 Jul 23
IGC Pharma Secures $12 Million Line of Credit from O-Bank
11:41am
8-K
EX-10.1
vh1d08ycb70p6sbih9
6 Jul 23
IGC Pharma Announces a $3 Million Private Placement of its Common Stock
5:52pm
8-K
EX-10.1
ehjk931ija 252
5 May 23
Departure of Directors or Certain Officers
6:19pm